JP2013533874A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013533874A5 JP2013533874A5 JP2013517481A JP2013517481A JP2013533874A5 JP 2013533874 A5 JP2013533874 A5 JP 2013533874A5 JP 2013517481 A JP2013517481 A JP 2013517481A JP 2013517481 A JP2013517481 A JP 2013517481A JP 2013533874 A5 JP2013533874 A5 JP 2013533874A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- amount
- particles
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 28
- 239000002245 particle Substances 0.000 claims 15
- 239000003605 opacifier Substances 0.000 claims 7
- 239000003795 chemical substances by application Substances 0.000 claims 6
- 235000013361 beverage Nutrition 0.000 claims 5
- 239000000203 mixture Substances 0.000 claims 5
- 210000000214 mouth Anatomy 0.000 claims 5
- 239000003086 colorant Substances 0.000 claims 4
- 150000001875 compounds Chemical class 0.000 claims 4
- 239000008203 oral pharmaceutical composition Substances 0.000 claims 4
- 230000001953 sensory effect Effects 0.000 claims 4
- 239000004480 active ingredient Substances 0.000 claims 3
- 239000007850 fluorescent dye Substances 0.000 claims 3
- 238000012986 modification Methods 0.000 claims 3
- 230000004048 modification Effects 0.000 claims 3
- 239000000126 substance Substances 0.000 claims 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims 2
- 239000011248 coating agent Substances 0.000 claims 2
- 238000000576 coating method Methods 0.000 claims 2
- -1 hypnotic Substances 0.000 claims 2
- 239000003826 tablet Substances 0.000 claims 2
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 1
- 239000004214 Fast Green FCF Substances 0.000 claims 1
- RZSYLLSAWYUBPE-UHFFFAOYSA-L Fast green FCF Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC(O)=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 RZSYLLSAWYUBPE-UHFFFAOYSA-L 0.000 claims 1
- OIQPTROHQCGFEF-QIKYXUGXSA-L Sunset Yellow FCF Chemical compound [Na+].[Na+].OC1=CC=C2C=C(S([O-])(=O)=O)C=CC2=C1\N=N\C1=CC=C(S([O-])(=O)=O)C=C1 OIQPTROHQCGFEF-QIKYXUGXSA-L 0.000 claims 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 claims 1
- CQPFMGBJSMSXLP-UHFFFAOYSA-M acid orange 7 Chemical compound [Na+].OC1=CC=C2C=CC=CC2=C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 CQPFMGBJSMSXLP-UHFFFAOYSA-M 0.000 claims 1
- 239000000654 additive Substances 0.000 claims 1
- 230000000996 additive effect Effects 0.000 claims 1
- SNAAJJQQZSMGQD-UHFFFAOYSA-N aluminum magnesium Chemical compound [Mg].[Al] SNAAJJQQZSMGQD-UHFFFAOYSA-N 0.000 claims 1
- 230000000202 analgesic effect Effects 0.000 claims 1
- 239000002249 anxiolytic agent Substances 0.000 claims 1
- 230000000949 anxiolytic effect Effects 0.000 claims 1
- 235000012745 brilliant blue FCF Nutrition 0.000 claims 1
- 239000004161 brilliant blue FCF Substances 0.000 claims 1
- 229940055580 brilliant blue fcf Drugs 0.000 claims 1
- 229910000019 calcium carbonate Inorganic materials 0.000 claims 1
- 239000000378 calcium silicate Substances 0.000 claims 1
- 229910052918 calcium silicate Inorganic materials 0.000 claims 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 239000007910 chewable tablet Substances 0.000 claims 1
- 230000010485 coping Effects 0.000 claims 1
- 239000007919 dispersible tablet Substances 0.000 claims 1
- 239000007938 effervescent tablet Substances 0.000 claims 1
- IINNWAYUJNWZRM-UHFFFAOYSA-L erythrosin B Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(I)C(=O)C(I)=C2OC2=C(I)C([O-])=C(I)C=C21 IINNWAYUJNWZRM-UHFFFAOYSA-L 0.000 claims 1
- 235000019240 fast green FCF Nutrition 0.000 claims 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 claims 1
- 230000000147 hypnotic effect Effects 0.000 claims 1
- KHLVKKOJDHCJMG-QDBORUFSSA-L indigo carmine Chemical compound [Na+].[Na+].N/1C2=CC=C(S([O-])(=O)=O)C=C2C(=O)C\1=C1/NC2=CC=C(S(=O)(=O)[O-])C=C2C1=O KHLVKKOJDHCJMG-QDBORUFSSA-L 0.000 claims 1
- 229960003988 indigo carmine Drugs 0.000 claims 1
- 235000012738 indigotine Nutrition 0.000 claims 1
- 239000004179 indigotine Substances 0.000 claims 1
- 229960004657 indocyanine green Drugs 0.000 claims 1
- MOFVSTNWEDAEEK-UHFFFAOYSA-M indocyanine green Chemical compound [Na+].[O-]S(=O)(=O)CCCCN1C2=CC=C3C=CC=CC3=C2C(C)(C)C1=CC=CC=CC=CC1=[N+](CCCCS([O-])(=O)=O)C2=CC=C(C=CC=C3)C3=C2C1(C)C MOFVSTNWEDAEEK-UHFFFAOYSA-M 0.000 claims 1
- 150000002484 inorganic compounds Chemical group 0.000 claims 1
- 229910010272 inorganic material Inorganic materials 0.000 claims 1
- 150000002632 lipids Chemical class 0.000 claims 1
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 claims 1
- 239000000391 magnesium silicate Substances 0.000 claims 1
- 229910052919 magnesium silicate Inorganic materials 0.000 claims 1
- 235000019792 magnesium silicate Nutrition 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 239000004531 microgranule Substances 0.000 claims 1
- 239000006191 orally-disintegrating tablet Substances 0.000 claims 1
- 238000012856 packing Methods 0.000 claims 1
- 229920000642 polymer Polymers 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- TVRGPOFMYCMNRB-UHFFFAOYSA-N quinizarine green ss Chemical compound C1=CC(C)=CC=C1NC(C=1C(=O)C2=CC=CC=C2C(=O)C=11)=CC=C1NC1=CC=C(C)C=C1 TVRGPOFMYCMNRB-UHFFFAOYSA-N 0.000 claims 1
- 239000000932 sedative agent Substances 0.000 claims 1
- 230000001624 sedative effect Effects 0.000 claims 1
- 150000004760 silicates Chemical class 0.000 claims 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims 1
- 235000017557 sodium bicarbonate Nutrition 0.000 claims 1
- 239000006190 sub-lingual tablet Substances 0.000 claims 1
- 235000012751 sunset yellow FCF Nutrition 0.000 claims 1
- 239000004173 sunset yellow FCF Substances 0.000 claims 1
- 235000012756 tartrazine Nutrition 0.000 claims 1
- 239000004149 tartrazine Substances 0.000 claims 1
- 229960000943 tartrazine Drugs 0.000 claims 1
- UJMBCXLDXJUMFB-GLCFPVLVSA-K tartrazine Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1\N=N\C1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-GLCFPVLVSA-K 0.000 claims 1
- 239000010409 thin film Substances 0.000 claims 1
- 239000004408 titanium dioxide Substances 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1055491A FR2962331B1 (fr) | 2010-07-06 | 2010-07-06 | Forme pharmaceutique pour lutter contre la soumission chimique, methode la mettant en oeuvre |
| FR1055491 | 2010-07-06 | ||
| PCT/FR2011/051601 WO2012007672A1 (fr) | 2010-07-06 | 2011-07-05 | Forme pharmaceutique pour lutter contre la soumission chimique d'un medicament |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013533874A JP2013533874A (ja) | 2013-08-29 |
| JP2013533874A5 true JP2013533874A5 (enExample) | 2014-08-21 |
Family
ID=43661911
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013517481A Pending JP2013533874A (ja) | 2010-07-06 | 2011-07-05 | 薬による化学的服従に対処するための医薬剤形 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US20130108556A1 (enExample) |
| EP (1) | EP2590632B1 (enExample) |
| JP (1) | JP2013533874A (enExample) |
| KR (1) | KR20130043180A (enExample) |
| CN (1) | CN103118667B (enExample) |
| AU (1) | AU2011278140B2 (enExample) |
| CA (1) | CA2802404C (enExample) |
| ES (1) | ES2733732T3 (enExample) |
| FR (1) | FR2962331B1 (enExample) |
| IL (1) | IL223887B (enExample) |
| MX (1) | MX344018B (enExample) |
| WO (1) | WO2012007672A1 (enExample) |
| ZA (1) | ZA201300077B (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2962550B1 (fr) * | 2010-07-06 | 2013-06-14 | Ethypharm Sa | Methode pour lutter contre la soumission chimique, utilisation d'agent colorant pour lutter contre la soumission chimique et composition pharmaceutique permettant la mise en oeuvre de la methode |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2679451B1 (fr) | 1991-07-22 | 1994-09-09 | Prographarm Laboratoires | Comprime multiparticulaire a delitement rapide. |
| US6649186B1 (en) * | 1996-09-20 | 2003-11-18 | Ethypharm | Effervescent granules and methods for their preparation |
| FR2766089B1 (fr) | 1997-07-21 | 2000-06-02 | Prographarm Lab | Comprime multiparticulaire perfectionne a delitement rapide |
| FR2785538B1 (fr) | 1998-11-06 | 2004-04-09 | Prographarm Laboratoires | Comprime a delitement rapide perfectionne |
| EP1005863A1 (en) * | 1998-12-04 | 2000-06-07 | Synthelabo | Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof |
| FR2787715B1 (fr) * | 1998-12-23 | 2002-05-10 | Synthelabo | Composition pharmaceutique comprenant un compose hypnotique ou un de ses sels pharmaceutiquement acceptables |
| FR2790387B1 (fr) | 1999-03-01 | 2001-05-18 | Prographarm Laboratoires | Comprime orodispersible presentant une faible friabilite et son procede de preparation |
| US20040258750A1 (en) * | 1999-06-28 | 2004-12-23 | Gerard Alaux | Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof |
| WO2001058424A1 (en) * | 2000-02-09 | 2001-08-16 | West Pharmaceutical Services Drug Delivery & Clinical Research Centre Limited | Floating drug delivery composition |
| ITMI20011446A1 (it) * | 2001-07-06 | 2003-01-06 | Altergon Sa | Composizioni farmaceutiche di principi attivi suscettibili di somministrazione illecita |
| FR2829932B1 (fr) * | 2001-09-21 | 2006-11-24 | Ellipse Pharmaceuticals | Procede de fabrication d'un produit pharmaceutique administrable par voie orale avec des agents detrompeurs et produit obtenu |
| FR2829933B3 (fr) * | 2001-09-21 | 2004-03-12 | Ellipse Pharmaceuticals | Procede de fabrication d'un produit pharmaceutique administrable par voie orale avec des agents detrompeurs notamment de gout et produit obtenu |
| FR2831820B1 (fr) | 2001-11-05 | 2004-08-20 | Ethypharm Sa | Comprime orodispersible presentant une grande homogeneite et son procede de preparation |
| US8906413B2 (en) * | 2003-05-12 | 2014-12-09 | Supernus Pharmaceuticals, Inc. | Drug formulations having reduced abuse potential |
| DE10336400A1 (de) * | 2003-08-06 | 2005-03-24 | Grünenthal GmbH | Gegen Missbrauch gesicherte Darreichungsform |
| US20080102482A1 (en) | 2003-12-19 | 2008-05-01 | Stanley Irwin Grossman | Apparatus for Detecting Drugs in a Beverage |
| US9308176B2 (en) * | 2004-10-15 | 2016-04-12 | Supernus Pharmaceuticals, Inc | Less abusable pharmaceutical preparations |
| EP1681048A1 (en) * | 2005-01-14 | 2006-07-19 | Krka Tovarna Zdravil, D.D., Novo Mesto | Orally disintegrating composition of olanzapine or donepezil |
| FR2892937B1 (fr) * | 2005-11-10 | 2013-04-05 | Flamel Tech Sa | Forme pharmaceutique orale microparticulaire anti-mesusage |
| WO2008033351A2 (en) * | 2006-09-11 | 2008-03-20 | Theraquest Biosciences, Inc. | Multimodal abuse resistant and extended release formulations |
| PL2572705T3 (pl) * | 2007-10-01 | 2018-01-31 | Lesvi Laboratorios Sl | Tabletki ulegające rozpadowi w jamie ustnej |
| EP2254420A4 (en) * | 2008-02-20 | 2012-02-15 | Targia Pharmaceuticals | CNS PHARMACEUTICALS AND METHOD FOR THEIR USE |
-
2010
- 2010-07-06 FR FR1055491A patent/FR2962331B1/fr active Active
-
2011
- 2011-07-05 US US13/808,810 patent/US20130108556A1/en not_active Abandoned
- 2011-07-05 CA CA2802404A patent/CA2802404C/fr active Active
- 2011-07-05 WO PCT/FR2011/051601 patent/WO2012007672A1/fr not_active Ceased
- 2011-07-05 CN CN201180033422.3A patent/CN103118667B/zh active Active
- 2011-07-05 KR KR1020137003074A patent/KR20130043180A/ko not_active Withdrawn
- 2011-07-05 MX MX2012015104A patent/MX344018B/es active IP Right Grant
- 2011-07-05 ES ES11743100T patent/ES2733732T3/es active Active
- 2011-07-05 EP EP11743100.7A patent/EP2590632B1/fr active Active
- 2011-07-05 JP JP2013517481A patent/JP2013533874A/ja active Pending
- 2011-07-05 AU AU2011278140A patent/AU2011278140B2/en not_active Ceased
-
2012
- 2012-12-25 IL IL223887A patent/IL223887B/en active IP Right Grant
-
2013
- 2013-01-03 ZA ZA2013/00077A patent/ZA201300077B/en unknown
-
2016
- 2016-09-30 US US15/281,595 patent/US20170016925A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2286119T3 (es) | Composicion de recubrimiento para enmascarar el sabor. | |
| US9504656B2 (en) | Pharmaceutical compositions for poorly soluble active ingredients | |
| ES2593210T3 (es) | Composiciones farmacéuticas mejoradas de pimobendán | |
| IL256924A (en) | Prebiotic formulations and methods for their use | |
| BRPI0808475A2 (pt) | Preparação de película de dissolução/desintegração rápida tendo proporção elevada de ativos | |
| WO2009069139A1 (en) | Dosage form providing an ibuprofen-containing liquid fill | |
| CA2873837C (en) | Acid resistant banding solution for two piece hard capsules | |
| US20210205236A1 (en) | Therapeutic combinations of boswellia extract and cannabinoids | |
| JP2013523676A5 (enExample) | ||
| JP2013530206A5 (enExample) | ||
| JPWO2018008660A1 (ja) | 硬度が改善された硬質カプセル、及びその製造方法 | |
| CN106456535A (zh) | 稳定的孟鲁司特溶液 | |
| ES2423929T3 (es) | Composición farmacéutica que contiene suspensión basada en aceite de partículas finas | |
| HRP20192227T1 (hr) | Dvojna uporaba oralnog farmaceutskog pripravka tableta sulfatnih soli i metode njihove uporabe | |
| ES2261006B1 (es) | Pellet multicapa de liberacion controlada de metilfenidato. | |
| US20210338629A1 (en) | Oral formulations of phenylalanine and cannabinoids | |
| KR101957657B1 (ko) | 음료 내의 약물을 검출하기 위한 방법 및 성분 | |
| JP2013533874A5 (enExample) | ||
| WO2013098268A3 (en) | Tablets and dry-coated agents | |
| JP2016512493A5 (enExample) | ||
| CN107106568B (zh) | 稠合氨基二氢噻嗪衍生物的药物组合物 | |
| EP2893928B1 (en) | Hydromorphone hydrochloride-containing oral sustained-release pharmaceutical composition | |
| ES2742034T3 (es) | Composición farmacéutica que contiene flurbiprofeno | |
| WO2008147169A2 (es) | Microemolsion conteniendo pirfenidona | |
| WO2012131476A1 (en) | Composition and method for controlling release of active ingredient |